Trial Profile
Open and exploratory trial to investigate the pharmacokinetic of ceftobiprole medocaril in patients with CSF device
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2020
Price :
$35
*
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Meningitis
- Focus Pharmacokinetics
- Acronyms BASILE
- 14 Sep 2020 Status changed from recruiting to completed.
- 11 Dec 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
- 11 Dec 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.